{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T09:37:20Z","timestamp":1793266640379,"version":"4.5.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R 01 DA053047"],"award-info":[{"award-number":["R 01 DA053047"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DA047180"],"award-info":[{"award-number":["R01 DA047180"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 ES007255"],"award-info":[{"award-number":["T32 ES007255"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jpet.2026.105010","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T15:51:42Z","timestamp":1786722702000},"page":"105010","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u03949-Tetrahydrocannabinol treatment impairs CD8+ T cell differentiation into interferon gamma-competent CD45RO+ cells"],"prefix":"10.1016","volume":"393","author":[{"given":"Joel R.","family":"Marty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8911-8843","authenticated-orcid":false,"given":"Lance K.","family":"Blevins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Gulick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert E.","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jpet.2026.105010_bib1","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.4049\/jimmunol.140.7.2171","article-title":"Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells","volume":"140","author":"Akbar","year":"1988","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.jpet.2026.105010_bib2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0167-5699(91)90050-4","article-title":"The synergy between naive and memory T cells during activation","volume":"12","author":"Akbar","year":"1991","journal-title":"Immunol Today"},{"issue":"2","key":"10.1016\/j.jpet.2026.105010_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110632","article-title":"Autocrine and paracrine IL-2 signals collaborate to regulate distinct phases of CD8 T cell memory","volume":"39","author":"Toumi","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.jpet.2026.105010_bib4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cyto.2016.08.003","article-title":"TNF activity and T cells","volume":"101","author":"Mehta","year":"2018","journal-title":"Cytokine"},{"issue":"40","key":"10.1016\/j.jpet.2026.105010_bib5","doi-asserted-by":"crossref","first-page":"14467","DOI":"10.1073\/pnas.0405947101","article-title":"IFN-gamma enables cross-presentation of exogenous protein antigen in human Langerhans cells by potentiating maturation","volume":"101","author":"Matsuo","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.jpet.2026.105010_bib6","doi-asserted-by":"crossref","first-page":"659","DOI":"10.4049\/jimmunol.1102727","article-title":"Autocrine IFN-\u03b3 promotes naive CD8 T cell differentiation and synergizes with IFN-\u03b1 to stimulate strong function","volume":"189","author":"Curtsinger","year":"2012","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.jpet.2026.105010_bib7","doi-asserted-by":"crossref","DOI":"10.4110\/in.2018.18.e33","article-title":"Direct antiviral mechanisms of interferon-gamma","volume":"18","author":"Kang","year":"2018","journal-title":"Immune Netw"},{"issue":"12","key":"10.1016\/j.jpet.2026.105010_bib8","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1182\/blood-2005-12-4818","article-title":"HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells","volume":"107","author":"Betts","year":"2006","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jpet.2026.105010_bib9","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJM199709113371102","article-title":"Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy","volume":"337","author":"Gulick","year":"1997","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jpet.2026.105010_bib10","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/nm1511","article-title":"Microbial translocation is a cause of systemic immune activation in chronic HIV infection","volume":"12","author":"Brenchley","year":"2006","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.jpet.2026.105010_bib11","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/COH.0000000000000234","article-title":"Microbial translocation and microbiome dysbiosis in HIV-associated immune activation","volume":"11","author":"Zevin","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"issue":"11","key":"10.1016\/j.jpet.2026.105010_bib12","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/infdis\/jit088","article-title":"Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection","volume":"207","author":"Peluso","year":"2013","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.jpet.2026.105010_bib13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/bpa.12038","article-title":"Encephalitis with infiltration by CD8+ lymphocytes in HIV patients receiving combination antiretroviral treatment","volume":"23","author":"Gray","year":"2013","journal-title":"Brain Pathol"},{"issue":"23","key":"10.1016\/j.jpet.2026.105010_bib14","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","article-title":"HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER study","volume":"75","author":"Heaton","year":"2010","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jpet.2026.105010_bib15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S2055-6640(20)30489-1","article-title":"CNS reservoirs for HIV: implications for eradication","volume":"1","author":"Hellmuth","year":"2015","journal-title":"J Virus Erad"},{"issue":"Suppl 2","key":"10.1016\/j.jpet.2026.105010_bib16","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1097\/QAD.0000000000002268","article-title":"Presence of Tat and transactivation response element in spinal fluid despite antiretroviral therapy","volume":"33","author":"Henderson","year":"2019","journal-title":"AIDS"},{"issue":"13","key":"10.1016\/j.jpet.2026.105010_bib17","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1523\/JNEUROSCI.3045-16.2017","article-title":"HIV-1 Tat primes and activates microglial NLRP3 inflammasome-mediated neuroinflammation","volume":"37","author":"Chivero","year":"2017","journal-title":"J Neurosci"},{"issue":"24","key":"10.1016\/j.jpet.2026.105010_bib18","doi-asserted-by":"crossref","first-page":"17098","DOI":"10.1074\/jbc.274.24.17098","article-title":"Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon","volume":"274","author":"Nath","year":"1999","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.jpet.2026.105010_bib19","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.4049\/jimmunol.163.5.2953","article-title":"HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes","volume":"163","author":"Weiss","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.jpet.2026.105010_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.628296","article-title":"HIV-associated CD8 encephalitis: a UK case series and review of histopathologically confirmed cases","volume":"12","author":"Lucas","year":"2021","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.jpet.2026.105010_bib21","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/QAI.0000000000001301","article-title":"High number of activated CD8+ T cells targeting HIV antigens are present in cerebrospinal fluid in acute HIV infection","volume":"75","author":"Kessing","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"10.1016\/j.jpet.2026.105010_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116526","article-title":"Cerebrospinal fluid (CSF) CD8+ T-cells that express interferon-gamma contribute to HIV associated neurocognitive disorders (HAND)","volume":"10","author":"Schrier","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.jpet.2026.105010_bib23","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.3390\/biomedicines11102630","article-title":"Therapeutic potential of cannabis: a comprehensive review of current and future applications","volume":"11","author":"Leinen","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jpet.2026.105010_bib24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.addbeh.2017.01.015","article-title":"Patterns of drug use and HIV infection among adults in a nationally representative sample","volume":"68","author":"Shiau","year":"2017","journal-title":"Addict Behav"},{"issue":"2","key":"10.1016\/j.jpet.2026.105010_bib25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1521\/aeap.2018.30.2.169","article-title":"Frequency of cannabis use and medical cannabis use among persons living with HIV in the United States: findings from a nationally representative sample","volume":"30","author":"Pacek","year":"2018","journal-title":"AIDS Educ Prev"},{"issue":"3","key":"10.1016\/j.jpet.2026.105010_bib26","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1089\/can.2018.0068","article-title":"Cannabis consumption in people living with HIV: reasons for use, secondary effects, and opportunities for health education","volume":"4","author":"Costiniuk","year":"2019","journal-title":"Cannabis Cannabinoid Res"},{"issue":"4","key":"10.1016\/j.jpet.2026.105010_bib27","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/QAD.0000000000001704","article-title":"HIV-infected cannabis users have lower circulating CD16+ monocytes and IFN-\u03b3-inducible protein 10 levels compared with nonusing HIV patients","volume":"32","author":"Rizzo","year":"2018","journal-title":"Aids"},{"issue":"51","key":"10.1016\/j.jpet.2026.105010_bib28","doi-asserted-by":"crossref","first-page":"35450","DOI":"10.1074\/jbc.M109.006338","article-title":"Cannabinoid receptor type 1- and 2-mediated increase in cyclic AMP inhibits T cell receptor-triggered signaling","volume":"284","author":"B\u00f6rner","year":"2009","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"10.1016\/j.jpet.2026.105010_bib29","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0165-5728(02)00370-3","article-title":"Delta 9-tetrahydrocannabinol regulates Th1\/Th2 cytokine balance in activated human T cells","volume":"133","author":"Yuan","year":"2002","journal-title":"J Neuroimmunol"},{"issue":"1","key":"10.1016\/j.jpet.2026.105010_bib30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.taap.2013.08.023","article-title":"Impaired NFAT and NF\u03baB activation are involved in suppression of CD40 ligand expression by \u0394(9)-tetrahydrocannabinol in human CD4(+) T cells","volume":"273","author":"Ngaotepprutaram","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"issue":"19","key":"10.1016\/j.jpet.2026.105010_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914880","article-title":"Effect of cannabidiol on human peripheral blood mononuclear cells and CD4+ T cells","volume":"24","author":"Furgiuele","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.jpet.2026.105010_bib32","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/j.1476-5381.2011.01379.x","article-title":"Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL\/6 mice","volume":"163","author":"Kozela","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.jpet.2026.105010_bib33","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1432-1033.1995.tb20780.x","article-title":"Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations","volume":"232","author":"Gali\u00e8gue","year":"1995","journal-title":"Eur J Biochem"},{"issue":"2","key":"10.1016\/j.jpet.2026.105010_bib34","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.bjp.0705931","article-title":"Marijuana and cannabinoid regulation of brain reward circuits","volume":"143","author":"Lupica","year":"2004","journal-title":"Br J Pharmacol"},{"issue":"2\u20133","key":"10.1016\/j.jpet.2026.105010_bib35","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0014-2999(00)00211-9","article-title":"Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor","volume":"396","author":"Buckley","year":"2000","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.jpet.2026.105010_bib36","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bcp.2008.06.022","article-title":"The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT)","volume":"76","author":"Kaplan","year":"2008","journal-title":"Biochem Pharmacol"},{"issue":"6284","key":"10.1016\/j.jpet.2026.105010_bib37","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"issue":"6441","key":"10.1016\/j.jpet.2026.105010_bib38","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.jpet.2026.105010_bib39","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1476-5381.2010.01166.x","article-title":"Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes","volume":"163","author":"De Petrocellis","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"1\u20133","key":"10.1016\/j.jpet.2026.105010_bib40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejphar.2009.03.010","article-title":"Time-dependent vascular actions of cannabidiol in the rat aorta","volume":"612","author":"O\u2019Sullivan","year":"2009","journal-title":"Eur J Pharmacol"},{"issue":"16","key":"10.1016\/j.jpet.2026.105010_bib41","doi-asserted-by":"crossref","first-page":"5980","DOI":"10.3390\/molecules28165980","article-title":"Molecular and cellular mechanisms of action of cannabidiol","volume":"28","author":"Martinez Naya","year":"2023","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.jpet.2026.105010_bib42","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.imbio.2009.04.001","article-title":"Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression","volume":"215","author":"Rieder","year":"2010","journal-title":"Immunobiology"},{"issue":"2","key":"10.1016\/j.jpet.2026.105010_bib43","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/cyto.990200205","article-title":"Rapid flow cytometric method for measuring lymphocyte subset activation","volume":"20","author":"Maino","year":"1995","journal-title":"Cytometry"},{"issue":"2","key":"10.1016\/j.jpet.2026.105010_bib44","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.immuni.2010.08.004","article-title":"Interleukin-2 receptor signaling: at the interface between tolerance and immunity","volume":"33","author":"Malek","year":"2010","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.jpet.2026.105010_bib45","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/QAD.0000000000001443","article-title":"Demographics and natural history of HIV-1-infected spontaneous controllers of viremia","volume":"31","author":"Yang","year":"2017","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.jpet.2026.105010_bib46","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1073\/pnas.050567397","article-title":"HLA B\u22175701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors","volume":"97","author":"Migueles","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/j.jpet.2026.105010_bib47","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41577-020-0274-9","article-title":"CD8+ T cells in HIV control, cure and prevention","volume":"20","author":"Collins","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"10.1016\/j.jpet.2026.105010_bib48","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1086\/605890","article-title":"Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4+ T cells","volume":"200","author":"French","year":"2009","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.jpet.2026.105010_bib49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12879-018-3643-2","article-title":"Clinical characteristics of HIV-1-infected patients with high levels of plasma interferon-\u03b3: a multicenter observational study","volume":"19","author":"Watanabe","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.jpet.2026.105010_bib50","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1128\/JVI.73.1.797-800.1999","article-title":"Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy","volume":"73","author":"Ogg","year":"1999","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.jpet.2026.105010_bib51","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/infdis\/jiad364","article-title":"Impact of cannabis use on immune cell populations and the viral reservoir in people with HIV on suppressive antiretroviral therapy","volume":"228","author":"Falcinelli","year":"2023","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.jpet.2026.105010_bib52","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s11481-020-09917-8","article-title":"CBD suppression of EAE is correlated with early inhibition of splenic IFN-\u03b3 + CD8+ T cells and modest inhibition of neuroinflammation","volume":"16","author":"Nichols","year":"2021","journal-title":"J Neuroimmune Pharmacol"},{"issue":"1","key":"10.1016\/j.jpet.2026.105010_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008688","article-title":"Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors","volume":"5","author":"Cencioni","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jpet.2026.105010_bib54","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International Union of Pharmacology. XXVII. Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol Rev"},{"issue":"3","key":"10.1016\/j.jpet.2026.105010_bib55","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0026-895X(25)10492-6","article-title":"Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors","volume":"48","author":"Felder","year":"1995","journal-title":"Mol Pharmacol"},{"issue":"2","key":"10.1016\/j.jpet.2026.105010_bib56","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0376-8716(99)00152-0","article-title":"Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB1 and CB2 receptor binding","volume":"60","author":"Aung","year":"2000","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"10.1016\/j.jpet.2026.105010_bib57","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000117809","article-title":"Activation of human T cells induces upregulation of cannabinoid receptor type 1 transcription","volume":"14","author":"B\u00f6rner","year":"2007","journal-title":"Neuroimmunomodulation"},{"issue":"5","key":"10.1016\/j.jpet.2026.105010_bib58","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.phrs.2012.08.002","article-title":"The CB2-preferring agonist JWH015 also potently and efficaciously activates CB1 in autaptic hippocampal neurons","volume":"66","author":"Murataeva","year":"2012","journal-title":"Pharmacol Res"},{"issue":"1","key":"10.1016\/j.jpet.2026.105010_bib59","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5487\/TR.2019.35.1.037","article-title":"Receptor binding affinities of synthetic cannabinoids determined by non-isotopic receptor binding assay","volume":"35","author":"Cha","year":"2019","journal-title":"Toxicol Res"},{"issue":"1","key":"10.1016\/j.jpet.2026.105010_bib60","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1189\/jlb.0505274","article-title":"Induction of intracellular calcium elevation by Delta9-tetrahydrocannabinol in T cells involves TRPC1 channels","volume":"79","author":"Rao","year":"2006","journal-title":"J Leukoc Biol"},{"issue":"21","key":"10.1016\/j.jpet.2026.105010_bib61","doi-asserted-by":"crossref","first-page":"15894","DOI":"10.1074\/jbc.M608287200","article-title":"Activation properties of heterologously expressed mammalian TRPV2: evidence for species dependence","volume":"282","author":"Neeper","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jpet.2026.105010_bib62","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fimmu.2013.00034","article-title":"The role of transient receptor potential vanilloid type-2 ion channels in innate and adaptive immune responses","volume":"4","author":"Santoni","year":"2013","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.jpet.2026.105010_bib63","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1073\/pnas.0711278105","article-title":"GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current","volume":"105","author":"Lauckner","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"18","key":"10.1016\/j.jpet.2026.105010_bib64","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aao1135","article-title":"GPR55 regulates intraepithelial lymphocyte migration dynamics and susceptibility to intestinal damage","volume":"2","author":"Sumida","year":"2017","journal-title":"Sci Immunol"},{"issue":"12","key":"10.1016\/j.jpet.2026.105010_bib65","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/bph.13497","article-title":"An update on PPAR activation by cannabinoids","volume":"173","author":"O\u2019Sullivan","year":"2016","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.jpet.2026.105010_bib66","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s11481-011-9293-4","article-title":"\u03949-tetrahydrocannabinol suppresses cytotoxic T lymphocyte function independent of CB1 and CB 2, disrupting early activation events","volume":"7","author":"Karmaus","year":"2012","journal-title":"J Neuroimmune Pharmacol"},{"issue":"4","key":"10.1016\/j.jpet.2026.105010_bib67","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s11481-020-09912-z","article-title":"\u03949-tetrahydrocannabinol (THC) impairs CD8+ T cell-mediated activation of astrocytes","volume":"15","author":"Henriquez","year":"2020","journal-title":"J Neuroimmune Pharmacol"},{"issue":"14","key":"10.1016\/j.jpet.2026.105010_bib68","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.lfs.2005.05.014","article-title":"Tetrahydrocannabinol suppresses immune function and enhances HIV replication in the huPBL-SCID mouse","volume":"77","author":"Roth","year":"2005","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.jpet.2026.105010_bib69","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0022-3565(24)37693-1","article-title":"Delta9-tetrahydrocannabinol induces apoptosis in macrophages and lymphocytes: involvement of Bcl-2 and caspase-1","volume":"286","author":"Zhu","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.jpet.2026.105010_bib70","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.clim.2006.11.002","article-title":"CB2 cannabinoid receptor agonist, JWH-015, triggers apoptosis in immune cells: potential role for CB2-selective ligands as immunosuppressive agents","volume":"122","author":"Lombard","year":"2007","journal-title":"Clin Immunol"},{"issue":"5","key":"10.1016\/j.jpet.2026.105010_bib71","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0192-0561(90)90118-7","article-title":"Differential suppression of T-cell subpopulations by THC (delta-9-tetrahydrocannabinol)","volume":"12","author":"Pross","year":"1990","journal-title":"Int J Immunopharmacol"},{"issue":"2","key":"10.1016\/j.jpet.2026.105010_bib72","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s11481-015-9603-3","article-title":"Effects of cannabinoids on T-cell function and resistance to infection","volume":"10","author":"Eisenstein","year":"2015","journal-title":"J Neuroimmune Pharmacol"},{"issue":"2","key":"10.1016\/j.jpet.2026.105010_bib73","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12768","article-title":"Potent T cell-mediated anti-inflammatory role of the selective CB2 agonist lenabasum in multiple sclerosis","volume":"48","author":"Tiberi","year":"2022","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"41","key":"10.1016\/j.jpet.2026.105010_bib74","doi-asserted-by":"crossref","first-page":"28514","DOI":"10.1074\/jbc.M114.574319","article-title":"Phosphatase CD45 both positively and negatively regulates T cell receptor phosphorylation in reconstituted membrane protein clusters","volume":"289","author":"Furlan","year":"2014","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.jpet.2026.105010_bib75","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1182\/blood-2003-06-2083","article-title":"CD45-associated protein inhibits CD45 dimerization and up-regulates its protein tyrosine phosphatase activity","volume":"103","author":"Takeda","year":"2004","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jpet.2026.105010_bib76","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01898-22","article-title":"Enforced dimerization of CD45 by the adenovirus E3\/49K protein inhibits T cell receptor signaling","volume":"97","author":"Windheim","year":"2023","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.jpet.2026.105010_bib77","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0008-8749(92)90329-N","article-title":"Phenotypic comparison of the three populations of human lymphocytes defined by CD45RO and CD45RA expression","volume":"145","author":"Prince","year":"1992","journal-title":"Cell Immunol"},{"issue":"5889","key":"10.1016\/j.jpet.2026.105010_bib78","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1126\/science.1157610","article-title":"Regulation of CD45 alternative splicing by heterogeneous ribonucleoprotein, hnRNPLL","volume":"321","author":"Oberdoerffer","year":"2008","journal-title":"Science"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526012103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526012103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T09:18:34Z","timestamp":1793265514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356526012103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":78,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0022356526012103"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.105010","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03949-Tetrahydrocannabinol treatment impairs CD8+ T cell differentiation into interferon gamma-competent CD45RO+ cells","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.105010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"105010"}}